Glucosamine Market Size To Reach $1,309.8 Million By 2030

Glucosamine Market Growth & Trends

The global glucosamine market is expected to reach USD 1309.8 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2023 to 2030. The growing application scope of the product in the manufacturing of nutritional supplements, which aid in the prevention of osteoarthritis among consumers is expected to fuel demand over the next seven years. 

An increasing number of vegan consumers particularly in developed countries including the U.S. is expected to be another driver for the industry over the forecast period. The product is primarily manufactured from crustaceans including shrimp and crab; however, Cargill and Cyanotech have pioneered vegetarian glucosamine by extracting the ingredient from ‘aspergillus niger’ fungi. 

The increasing population, rapidly growing healthcare industry, and consumer awareness regarding joint and bone health is expected to fuel the use of glucosamine in various food & beverage products. In addition, supporting regulatory framework in Europe regarding product use in the manufacturing of food & beverages is expected to propel industry growth over the next seven years. However, an increasing number of substitutes including fish oil and omega-3 may challenge product demand over the forecast period. 

 Request a free sample copy or view report summary: Glucosamine Market Report

Glucosamine Market Report Highlights

• The glucosamine sulfate segment accounted for the largest revenue share of 61.1% in 2022. Glucosamine sulfate has been one of the most widely used forms of glucosamine in dietary supplements and pharmaceuticals

• The glucosamine hydrochloride segment is expected to grow at the second-fastest CAGR of 5.2% over the forecast period. Glucosamine hydrochloride is a compound commonly used as a dietary supplement to support joint health

• The supplement segment held the largest revenue share of 79.9% in 2022. These supplements are mainly manufactured from crustaceans including shrimp and crabs, however, increasing instances of allergy and a rising number of vegans, particularly in the U.S., have led manufacturers to develop the product from fungi and other plant sources

• Asia Pacific dominated the market and accounted for the largest revenue share of 47.9% in 2022. The Asia Pacific region, encompassing countries like China, Japan, India, and Australia, boasts a substantial and expanding population, with a simultaneous surge in health and wellness awareness across the area

Glucosamine Market Segmentation

Grand View Research has segmented the global glucosamine market on the basis of product, application and region:

Glucosamine Product Outlook (Revenue, USD Million, Volume, Tons, 2018 - 2030)

• Glucosamine Sulfate

• Glucosamine Hydrochloride

• N-acetyl glucosamine

• Others

Glucosamine Application Outlook (Revenue, USD Million, Volume, Tons, 2018 - 2030)

• Supplement

• Food and Beverage

• Others

Glucosamine Regional Outlook (Revenue, USD Million, Volume, Tons, 2018 - 2030)

• North America

  • U.S.

  • Canada.

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • Japan

  • India

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

  • Saudi Arabia

List of Key Players in the Glucosamine Market

• Koyo Chemical Industry Co., Ltd

• Laboratoires Expanscience

• Nutramax Laboratories Consumer Care, Inc.

• Amway

• CELLMARK AB.

• Alfa Chemical Group

• Cargill, Incorporated

• Golden-Shell Pharmaceutical

• SimplySupplements